Males or females 35 to 75 years of age at the time of signing the informed consent form (ICF).
Considered to be generally healthy based on medical history, physical examination, and the re-sults of vital signs, electrocardiogram, and clinical laboratory tests performed during the screening visit, as judged by the investigator.
Body mass index (BMI) 20 to 35 kilogram per meter square (kg/m2) (both inclusive) at screening.
Serum uric acid levels greater than or equal to (≥) 6.8 miligram per decileter (mg/dL) to less than or equal (≤) 12 mg/dL on 2 consecutive screening samples (the first at the screening visit \[V1\], and the second taken at V2 \[day -1\]; samples at least 7 days apart).
You may not be if
Female who is pregnant, breastfeeding, or intends to become pregnant or is of childbearing po-tential and not using an adequate contraceptive method.
Male of reproductive age who, or whose female partner(s), is not using an adequate contraceptive method.
Present or prior history of gout, or present or prior use of serum Uric acid (sUA) lowering medication.
Serious cardiovascular or hepatic disease, current or past malignancies, or chronic debilitating neurologic, gastrointestinal, or inflammatory diseases.
History or current diagnosis of chronic history kidney disease.
Screening alanine transaminase (ALT) or aspartate aminotransferase (AST) values greater than (\>) 2 multiply by (×) upper limit normal (ULN) or total bilirubin \>1.5× ULN.
Clareo Health | A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
